• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,763.91 261.79
( 0.34%)
Global Indices
Nasdaq
52,921.07 594.83
(1.14%)
Dow Jones
7,504.24 0.01
(0.00%)
Hang Seng
69,733.68 1,000.53
(1.46%)
Nikkei 225
10,673.34 20.47
(0.19%)
Forex
USD-INR
95.28 0.28
(0.30%)
EUR-INR
108.75 0.54
(0.50%)
GBP-INR
126.99 1.06
(0.84%)
JPY-INR
0.59 0.01
(0.97%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
152.25
456989.34
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.84
 

corpus ltd
Arunjyoti Bio Ventures reports standalone net loss of Rs 5.40 crore in the March 2026 quarter
May 14,2026
Net Loss of Arunjyoti Bio Ventures reported to Rs 5.40 crore in the quarter ended March 2026 as against net loss of Rs 1.99 crore during the previous quarter ended March 2025. Sales rose 37.12% to Rs 7.24 crore in the quarter ended March 2026 as against Rs 5.28 crore during the previous quarter ended March 2025.

For the full year,net loss reported to Rs 4.54 crore in the year ended March 2026 as against net loss of Rs 0.28 crore during the previous year ended March 2025. Sales declined 0.47% to Rs 27.75 crore in the year ended March 2026 as against Rs 27.88 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales7.245.28 37 27.7527.88 0
OPM %-32.736.44 -10.4118.01 -
PBDT-2.69-0.24 -1021 0.962.71 -65
PBT-3.56-1.04 -242 -2.40-0.34 -606
NP-5.40-1.99 -171 -4.54-0.28 -1521